Hoberman Kenneth 5
5 · STEMLINE THERAPEUTICS INC · Filed Feb 14, 2020
Insider Transaction Report
Form 5
Hoberman Kenneth
Chief Operating Officer
Transactions
- Gift
Stock Options (right to buy)
2019-06-12−18,070→ 0 totalExercise: $2.92Exp: 2021-03-08→ Common Stock (18,070 underlying) - Gift
Stock Options (right to buy)
2019-06-12−18,070→ 0 totalExercise: $2.92From: 2013-01-29Exp: 2021-03-08→ Common Stock (18,070 underlying) - Gift
Stock Options (right to buy)
2019-06-12−97,580→ 0 totalExercise: $3.30Exp: 2022-03-09→ Common Stock (97,580 underlying) - Gift
Stock Options (right to buy)
2019-06-12−75,000→ 0 totalExercise: $5.77Exp: 2026-01-07→ Common Stock (75,000 underlying) - Gift
Stock Options (right to buy)
2019-06-12−132,176→ 0 totalExercise: $4.12Exp: 2026-02-24→ Common Stock (132,176 underlying)
Footnotes (4)
- [F1]On June 12, 2019, options to purchase shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Hoberman's minor children. Mr. Hoberman is not a trustee of the trust and has no investment control over the securities held by the trust.
- [F2]Represents options to purchase shares of common stock that vested 25% per year on each of the first four anniversaries of the grant date. All options have a 10-year life.
- [F3]Represents options to purchase shares of common stock that vested 25% on the first anniversary and the remaining 75% vested quarterly over a three-year period.
- [F4]Represents options to purchase shares of common stock that vested in three equal installments on each of the first three anniversaries of the January 7, 2016 grant date.